Transplant Associated Thrombotic Microangiopathy (TA-TMA) Is Mechanistically Different in Adults and Children- a MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium Study

Key Points

• Thrombotic microangiopathy manifests differently in adults and children, impacting treatment strategies.
• Key metrics indicate that the endothelial damage mechanisms differ based on age group, likely influencing patient outcomes.
• Assessment using data from the MIDAS Consortium highlights the pathophysiological variations in adults undergoing stem cell transplantation.
• This work supports the need for age-specific approaches to prevent vascular complications related to transplant-associated conditions.